Frailty as a Predictor of Negative Health Outcomes in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Journal of the American Medical Directors Association
Fan MeiB Ma

Abstract

To perform a comprehensive evidence synthesis to summarize the impact of frailty on health outcomes in patients with chronic kidney disease (CKD). Systematic reviews and meta-analysis. Electronic searches in PubMed, Embase, Web of Science, CNKI, VIP, CBM, and Wanfang Database were performed. The methodological quality was evaluated using the Newcastle Ottawa Scale (NOS). Patients with chronic kidney disease (CKD). Potential clinical outcomes due to frailty. Eighteen cohort studies incorporating a total of 22,788 participants were included. The overall risk of bias was low. The median reported prevalence of frail and prefrail individuals with CKD was 41.8% (range 2.8-81.5%) and 43.9% (range 19.1-62.7%), respectively. Prefrailty and frailty related to mortality indicated an increased hazard ratio (HR), with a pooled HR of 1.68 [95% confidence interval (CI) 1.46-1.94; P < .001] and 1.48 (95% CI 1.21-1.81; P < .001), respectively. Prefrailty and frailty related to hospitalization with the pooled HR/risk ratio (RR) of 1.56 (95% CI 1.37-1.76; P < .001) and 1.21 (95% CI 0.79-1.85; P = .38), respectively. Similarly, the pooled HR demonstrated a strong correlation between frailty and falls in patients with CKD with HR 1.83 (95% CI 1.40-...Continue Reading

References

Dec 29, 1988·The New England Journal of Medicine·M E TinettiS F Ginter
Jun 23, 1994·The New England Journal of Medicine·M A FiataroneW J Evans
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L P FriedUNKNOWN Cardiovascular Health Study Collaborative Research Group
Apr 21, 2005·BMC Medical Research Methodology·Stela Pudar HozoIztok Hozo
Mar 1, 2006·Archives of Internal Medicine·Thomas M GillLing Han
Oct 19, 2007·Journal of the American Society of Nephrology : JASN·Kirsten L JohansenNancy G Kutner
Jun 30, 2009·The American Journal of Medicine·Emilee R Wilhelm-LeenGlenn M Chertow
Sep 30, 2009·Journal of Women's Health·Ivonne-Marie BergesKenneth J Ottenbacher
May 5, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kenneth RockwoodArnold Mitnitski
Jun 27, 2012·Archives of Internal Medicine·Yeran BaoKirsten L Johansen
Aug 14, 2012·Journal of the American Geriatrics Society·Rose M CollardRichard C Oude Voshaar
Oct 17, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN National Kidney Foundation
Feb 12, 2013·Lancet·Andrew CleggKenneth Rockwood
Apr 20, 2013·Journal of the American Society of Nephrology : JASN·Baback RoshanravanStephen Seliger
May 29, 2013·Journal of the American Geriatrics Society·Mara A McAdams-DeMarcoDorry L Segev
Mar 29, 2014·Geriatrics & Gerontology International·Jenni KulmalaSirpa Hartikainen
Nov 19, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C HandforthJ Young
Mar 6, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Talal A AlfaadhelKarthik K Tennankore
Aug 25, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Karen Bandeen-RocheJudith D Kasper
Sep 19, 2015·American Journal of Nephrology·Cynthia DelgadoKirsten L Johansen
Oct 9, 2015·Current Opinion in Nephrology and Hypertension·Clara BohmNavdeep Tangri
Jun 28, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Marije H KallenbergSimon P Mooijaart
Oct 25, 2016·Kidney & Blood Pressure Research·Jack Kit-Chung NgCheuk-Chun Szeto
Oct 27, 2016·European Journal of Clinical Nutrition·G H B Greenhall, A Davenport
Nov 5, 2016·Archives of Gerontology and Geriatrics·Rakin ChowdhuryRuth E Hubbard
Nov 25, 2016·Frontiers in Public Health·Mamta V KaraniRobin Lee
Nov 26, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Shoshana H BallewMorgan E Grams
Nov 26, 2016·Journal of the American Medical Directors Association·Sofie VermeirenUNKNOWN Gerontopole Brussels Study group
Nov 27, 2016·Lancet·Angela C WebsterPhilip Masson
Jan 4, 2017·Experimental Gerontology·E H GordonR E Hubbard
Jan 18, 2017·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Manjusha YadlaMahesh Mummadi
Feb 16, 2017·Current Opinion in Nephrology and Hypertension·Ranjani N Moorthi, Keith G Avin
Apr 16, 2017·Seminars in Nephrology·Anoop Sheshadri, Kirsten L Johansen
May 17, 2017·BMC Geriatrics·Laura Lorenzo-LópezJosé C Millán-Calenti
Jun 4, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Kirsten L JohansenGeorge A Kaysen
Jul 14, 2017·American Journal of Physiology. Renal Physiology·Jeroen P KoomanPeter Stenvinkel
Sep 14, 2017·Current Opinion in Nephrology and Hypertension·John Sy, Kirsten L Johansen
Nov 15, 2017·Journal of the American Medical Directors Association·Emily H Gordon, Ruth E Hubbard

❮ Previous
Next ❯

Citations

Jan 26, 2021·Journal of the American Medical Directors Association·Leocadio Rodríguez-Mañas, Isabel Rodriguez-Sánchez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.